Please login to the form below
3
Revenue 2017Roche
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Roche's 2013 sales performance.
Roche reveals four-year follow-up data for Venclyxto in CLL at EHA2021
Roche has revealed new data from various late-stage trials evaluating its AbbVie-partnered BCL-2 inhibitor Venclyxto, including four-year follow-up analysis from the phase 3 CLL14 study. . ... head of global product development, Roche.
Targacept picks Solvay's Stephen Hill to fill vacant CEO post
Prior to that, he served at US biotech ArQule and Roche, where he held several leadership positions including global head of clinical development.
Finalists 2021
by Lexington. for Roche Diagnostics. Heart Failure: The Hidden Costs of Late Diagnosis. ... by Lexington. for Roche Diagnostics. Creating a movement in dermatology: Clear Horizons UK.
J&J exits $1.6bn blood cancer drug licensing deal with argenx
The ongoing, early-stage trial is evaluating cusatuzumab in combination with AbbVie/Roche’s Venclexta (venetoclax) and chemotherapy Vidaza (azacitidine) in newly-diagnosed, elderly patients with AML.
EC approves Venclyxto-based combinations for newly diagnosed AML
The European Commission (EC) has approved Roche and AbbVie’s Venclyxto in combination with azacitidine and decitabine for the treatment of newly diagnosed acute myeloid leukaemia (AML) patients who can’t ... for, intensive chemotherapy,” said Levi
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
-
Senior Account Manager
-
Salary TBC
- Client Services Director, Patient Engagement & Solutions, Lo...
-
Highly competitive salary
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
-
Publications Director
-
Competitive Salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Group Account Director, Patient Engagement & Solutions, Lond...
-
Highly competitive salary
-
Planner
-
Salary TBC
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- Merck signs $1.2bn supply deal with US government for Molnupiravir
- AZ, Pfizer/BioNTech COVID-19 vaccines 'highly effective' against Indian variant
- Piloting a route to the biosimilars opportunities in Europe
- FDA approves Biogen’s aducanumab for Alzheimer’s disease in ‘landmark’ decision
- Biogen, Sage’s depression therapeutic zuranolone hits primary endpoint in phase 3
- The power of communication: Engaging diverse groups in healthcare
- US trial data shows Novavax’s COVID-19 vaccine is 90% effective
- AZ’s long-acting COVID-19 antibody fails to meet primary endpoint in prevention trial
- J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma
- Novartis’ iptacopan scores positive results in rare blood disorder PNH
No results were found
PMHub
Mind+Matter
We are Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for our...
Latest intelligence
- The power of communication: Engaging diverse groups in healthcare
- Humans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to a group, a cohort or an imagined section of society - especially...
- Building the hospital of the future
- Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....
- Why people join a clinical trial
- To understand why people decide to take part in clinical trials, you first need to understand how people make decisions....
